These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8016393)

  • 21. Ridogrel as an adjunct to thrombolysis in acute myocardial infarction.
    van der Wieken LR; Simoons ML; Laarman GJ; Van den Brand M; Nijssen KM; Dellborg M; Hermens W; Vrolik W
    Int J Cardiol; 1995 Nov; 52(2):125-34. PubMed ID: 8749872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of a combined administration of ridogrel and ketanserin in patients with intermittent claudication.
    De Cree J; Geukens H; Gutwirth P; De Clerck F; Vercammen E; Verhaegen H
    Int Angiol; 1993 Mar; 12(1):59-68. PubMed ID: 8376914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.
    Weber C; Beetens JR; Tegtmeier F; Van Rooy P; Vercammen E; Wouters L; De Clerck F
    Thromb Haemost; 1992 Aug; 68(2):214-20. PubMed ID: 1412169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
    Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
    N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
    Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: anti-inflammatory profile in inflammatory bowel disease.
    Carty E; Macey M; McCartney SA; Rampton DS
    Aliment Pharmacol Ther; 2000 Jun; 14(6):807-17. PubMed ID: 10848666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-derived thromboxane A2 decreases microvascular perfusion after arterial repair.
    O'Shaughnessy M; Anderson GL; Acland RD; Barker JH
    Plast Reconstr Surg; 1997 Mar; 99(3):834-41. PubMed ID: 9047204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
    Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F
    Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
    De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
    Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.
    De Clerck F; Loots W; Somers Y; Beetens J; Wouters L; Wynants J; Janssen PA
    Br J Pharmacol; 1990 Apr; 99(4):631-6. PubMed ID: 2113823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic antiplatelet effect of ridogrel, a combined thromboxane receptor antagonist and thromboxane synthase inhibitor, and UDCG-212, a cAMP-phosphodiesterase inhibitor.
    Hoet B; Arnout J; Deckmyn H; Vermylen J
    Thromb Haemost; 1993 Nov; 70(5):822-5. PubMed ID: 8128441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the bioisosteric potential of diazines: diazine analogues of the combined thromboxane A2 receptor antagonist and synthetase inhibitor Ridogrel.
    Heinisch G; Holzer W; Kunz F; Langer T; Lukavsky P; Pechlaner C; Weissenberger H
    J Med Chem; 1996 Sep; 39(20):4058-64. PubMed ID: 8831771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ridogrel prevents the thromboxane-mediated pressor response and oedema induced by hydrogen peroxide in isolated rabbit lungs.
    Corten I; Peeters FA; Rampart M; Bult H; Buyssens N; Herman AG
    Eur J Pharmacol; 1991 Aug; 201(1):83-90. PubMed ID: 1794415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Ridogrel, a thromboxane receptor blocker and synthesis inhibitor on plasma and red blood cell flow in an arterial skin flap in sheep.
    Banic A; Kouris K; Rajacic N; Nazzal M; al-Ghussain NM; Thulesius O
    Scand J Plast Reconstr Surg Hand Surg; 1991; 25(1):9-14. PubMed ID: 1828908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ridogrel. R 68070.
    Drugs R D; 1999 Mar; 1(3):270-2. PubMed ID: 10566044
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of ridogrel on vascular contractions caused by vasoactive substances released during platelet activation.
    Janssens WJ; Cools FJ; Hoskens LA; Van Nueten JM
    Thromb Haemost; 1990 Aug; 64(1):91-6. PubMed ID: 2148850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of thromboxane synthetase inhibition on platelet function and morphology during ovine pregnancy-induced hypertension.
    Miller KW; Keith JC
    Thromb Haemost; 1988 Dec; 60(3):365-71. PubMed ID: 3238644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ridogrel enemas in distal ulcerative colitis.
    Auwerda JJ; Zijlstra FJ; Tak CJ; van den Ingh HF; Wilson JH; Ouwendijk RJ
    Eur J Gastroenterol Hepatol; 2001 Apr; 13(4):397-400. PubMed ID: 11338069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo.
    De Clerck F; Beetens J; Van de Water A; Vercammen E; Janssen PA
    Thromb Haemost; 1989 Feb; 61(1):43-9. PubMed ID: 2526385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual inhibition of thromboxane A2 synthesis and thromboxane A2/prostaglandin endoperoxide receptors by ridogrel: anti-thrombotic effect in vivo in rat mesenteric arteries.
    Bourgain RH; Andries R; Decuyper K; De Clerck F
    J Lipid Mediat; 1991; 3(1):3-11. PubMed ID: 1837488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.